Belur; Lalitha R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Belur; Lalitha R..The latest application filed is for "intranasal administration of adeno-associated virus to treat central nervous system disorders".

Company Profile

6.1.18

Belur; Lalitha R. - St. Paul MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Intranasal Administration Of Adeno-associated Virus To Treat Central Nervous System Disorders App 20220211875 - McIvor; R. Scott ; et al.	2022-07-07
Method For Improving Neurological Function In Mpsi And Mpsii And Other Neurological Disorders App 20220096659 - Laoharawee; Kanut ; et al.	2022-03-31
Adeno-associated Virus For Therapeutic Delivery To Central Nervous System App 20210369871 - McIvor; R. Scott ; et al.	2021-12-02
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20210346473 - McIvor; R. Scott ; et al.	2021-11-11
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20210085760 - McIvor; R. Scott ; et al.	2021-03-25
Methods To Treat Pompe Disease Using A Recombinant Adeno-associated Virus App 20210085759 - McIvor; R. Scott ; et al.	2021-03-25
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20190298812 - McIvor; R. Scott ; et al.	2019-10-03
Method For Improving Neurological Function In Mpsi And Mpsii And Other Neurological Disorders App 20190269799 - LAOHARAWEE; Kanut ; et al.	2019-09-05
Intranasal Therapeutic Delivery Of Adeno-associated Virus To Central Nervous System App 20180289839 - McIvor; R. Scott ; et al.	2018-10-11
Methods To Treat Ceroid Lipofuscinosis Using A Recombinant Adeno-associated Virus App 20180271957 - McIvor; R. Scott ; et al.	2018-09-27
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20180271955 - McIvor; R. Scott ; et al.	2018-09-27
Methods To Treat Pompe Disease Using A Recombinant Adeno-associated Virus App 20180271956 - McIvor; R. Scott ; et al.	2018-09-27
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20180264090 - McIvor; R. Scott ; et al.	2018-09-20
Methods To Treat Mucopolysaccharide Type Ii Or Deficiency In Iduronate-2-sulfatase Using A Recombinant Adeno-associated Virus Encoding Iduronate-2-sulfatase App 20180099030 - McIvor; R. Scott ; et al.	2018-04-12
Adeno-associated Virus For Therapeutic Delivery To Central Nervous System App 20180071373 - McIvor; R. Scott ; et al.	2018-03-15
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20180036388 - McIvor; R. Scott ; et al.	2018-02-08
Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase Grant 9,827,295 - McIvor , et al. November 28, 2	2017-11-28
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20160120960 - McIvor; R. Scott ; et al.	2016-05-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.